Growth Metrics

Biogen (BIIB) Other Working Capital Changes (2016 - 2026)

Biogen has reported Other Working Capital Changes over the past 18 years, most recently at $89.0 million for Q1 2026.

  • For Q1 2026, Other Working Capital Changes rose 66.36% year-over-year to $89.0 million; the TTM value through Mar 2026 reached $96.1 million, up 276.86%, while the annual FY2025 figure was $60.6 million, 115.66% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was $89.0 million at Biogen, up from -$119.3 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $213.6 million in Q1 2022 and troughed at -$149.9 million in Q3 2022.
  • A 5-year average of $11.8 million and a median of $22.0 million in 2025 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: crashed 1445.36% in 2022 and later skyrocketed 379.89% in 2025.
  • Year by year, Other Working Capital Changes stood at $34.9 million in 2022, then plummeted by 291.4% to -$66.8 million in 2023, then skyrocketed by 43.71% to -$37.6 million in 2024, then crashed by 217.29% to -$119.3 million in 2025, then skyrocketed by 174.6% to $89.0 million in 2026.
  • Business Quant data shows Other Working Capital Changes for BIIB at $89.0 million in Q1 2026, -$119.3 million in Q4 2025, and $104.4 million in Q3 2025.